Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 87 | 2024 | 15165 | 4.620 |
Why?
|
Lipoproteins | 22 | 2022 | 878 | 4.190 |
Why?
|
Cholesterol, HDL | 32 | 2023 | 1814 | 4.070 |
Why?
|
Cholesterol, LDL | 43 | 2023 | 2356 | 3.970 |
Why?
|
Lipoproteins, LDL | 16 | 2020 | 640 | 3.650 |
Why?
|
Fasting | 19 | 2021 | 1593 | 3.450 |
Why?
|
Lipoprotein(a) | 15 | 2024 | 435 | 3.330 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 33 | 2024 | 3255 | 3.260 |
Why?
|
Triglycerides | 33 | 2022 | 2454 | 3.020 |
Why?
|
Fluorobenzenes | 9 | 2014 | 183 | 2.750 |
Why?
|
Atherosclerosis | 27 | 2023 | 3445 | 2.230 |
Why?
|
Amino Acids, Branched-Chain | 9 | 2022 | 251 | 2.110 |
Why?
|
Primary Prevention | 15 | 2022 | 1167 | 2.070 |
Why?
|
Lipids | 15 | 2021 | 3305 | 2.020 |
Why?
|
Dyslipidemias | 9 | 2022 | 849 | 2.000 |
Why?
|
Aspirin | 13 | 2022 | 3282 | 1.890 |
Why?
|
Fatty Acids, Omega-3 | 17 | 2023 | 1344 | 1.850 |
Why?
|
Lipoproteins, HDL | 9 | 2020 | 638 | 1.800 |
Why?
|
Polysaccharides | 9 | 2024 | 1053 | 1.730 |
Why?
|
Women's Health | 15 | 2021 | 2034 | 1.720 |
Why?
|
Sulfonamides | 10 | 2017 | 1938 | 1.630 |
Why?
|
Coronary Disease | 14 | 2023 | 6077 | 1.590 |
Why?
|
Hypertriglyceridemia | 6 | 2021 | 293 | 1.440 |
Why?
|
Postprandial Period | 9 | 2020 | 292 | 1.380 |
Why?
|
C-Reactive Protein | 16 | 2022 | 3778 | 1.380 |
Why?
|
Pyrimidines | 9 | 2014 | 2942 | 1.350 |
Why?
|
Inflammation | 19 | 2024 | 10638 | 1.350 |
Why?
|
Apolipoprotein A-I | 7 | 2020 | 281 | 1.330 |
Why?
|
Lipoproteins, VLDL | 7 | 2020 | 201 | 1.150 |
Why?
|
Exercise | 9 | 2022 | 5615 | 1.150 |
Why?
|
Diet, Mediterranean | 4 | 2022 | 700 | 1.140 |
Why?
|
Platelet Aggregation Inhibitors | 10 | 2022 | 3068 | 1.130 |
Why?
|
Cholesterol | 12 | 2023 | 2917 | 1.080 |
Why?
|
Acute-Phase Proteins | 6 | 2023 | 262 | 1.080 |
Why?
|
Acetylglucosamine | 4 | 2023 | 191 | 1.070 |
Why?
|
Risk Factors | 86 | 2024 | 72290 | 1.050 |
Why?
|
Risk Assessment | 34 | 2023 | 23338 | 1.050 |
Why?
|
Diabetes Mellitus, Type 2 | 20 | 2023 | 11725 | 1.030 |
Why?
|
Apolipoproteins B | 7 | 2023 | 374 | 1.010 |
Why?
|
Exercise Test | 6 | 2021 | 2074 | 1.000 |
Why?
|
Cholecalciferol | 9 | 2024 | 537 | 0.970 |
Why?
|
Hyperlipidemias | 3 | 2021 | 789 | 0.960 |
Why?
|
Magnetic Resonance Spectroscopy | 12 | 2020 | 3760 | 0.860 |
Why?
|
Insulin Resistance | 10 | 2022 | 3864 | 0.860 |
Why?
|
Particle Size | 11 | 2023 | 1642 | 0.840 |
Why?
|
Apolipoproteins | 6 | 2022 | 317 | 0.820 |
Why?
|
Middle Aged | 109 | 2023 | 213383 | 0.800 |
Why?
|
Humans | 207 | 2024 | 744343 | 0.790 |
Why?
|
Female | 139 | 2024 | 380194 | 0.770 |
Why?
|
Ventricular Premature Complexes | 1 | 2021 | 111 | 0.750 |
Why?
|
Glycosylation | 9 | 2024 | 1126 | 0.720 |
Why?
|
Group II Phospholipases A2 | 1 | 2019 | 13 | 0.710 |
Why?
|
Dietary Supplements | 18 | 2023 | 3297 | 0.690 |
Why?
|
Incidence | 27 | 2022 | 20947 | 0.680 |
Why?
|
Proportional Hazards Models | 19 | 2021 | 12354 | 0.660 |
Why?
|
Coronary Artery Disease | 8 | 2022 | 6487 | 0.660 |
Why?
|
Anticholesteremic Agents | 4 | 2016 | 979 | 0.660 |
Why?
|
Blood Chemical Analysis | 5 | 2019 | 440 | 0.640 |
Why?
|
Kringles | 1 | 2017 | 6 | 0.630 |
Why?
|
Glycoproteins | 2 | 2016 | 2263 | 0.630 |
Why?
|
Tunica Intima | 3 | 2012 | 464 | 0.630 |
Why?
|
Carbohydrates | 1 | 2020 | 394 | 0.630 |
Why?
|
Spouses | 1 | 2020 | 286 | 0.620 |
Why?
|
Aged | 75 | 2024 | 163280 | 0.610 |
Why?
|
Apolipoprotein B-100 | 3 | 2020 | 148 | 0.610 |
Why?
|
Acute Coronary Syndrome | 4 | 2020 | 2337 | 0.600 |
Why?
|
Follow-Up Studies | 33 | 2022 | 39050 | 0.600 |
Why?
|
Inflammation Mediators | 3 | 2018 | 1889 | 0.600 |
Why?
|
Vitamin D | 13 | 2023 | 3223 | 0.590 |
Why?
|
Fishes | 1 | 2020 | 569 | 0.580 |
Why?
|
Calcinosis | 2 | 2022 | 1499 | 0.580 |
Why?
|
Body Mass Index | 19 | 2022 | 12720 | 0.560 |
Why?
|
Acetylgalactosamine | 1 | 2016 | 37 | 0.560 |
Why?
|
Double-Blind Method | 22 | 2022 | 12026 | 0.560 |
Why?
|
Prospective Studies | 34 | 2023 | 53288 | 0.530 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 783 | 0.500 |
Why?
|
Male | 91 | 2024 | 350118 | 0.500 |
Why?
|
Light | 1 | 2021 | 1374 | 0.500 |
Why?
|
Tunica Media | 2 | 2012 | 113 | 0.490 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 711 | 0.480 |
Why?
|
Obesity | 14 | 2023 | 12745 | 0.470 |
Why?
|
Heart Rate | 4 | 2021 | 4091 | 0.470 |
Why?
|
Deoxyglucose | 1 | 2014 | 337 | 0.470 |
Why?
|
Myocardial Ischemia | 2 | 2018 | 2148 | 0.460 |
Why?
|
Heptanoic Acids | 2 | 2014 | 343 | 0.460 |
Why?
|
Carotid Artery Diseases | 2 | 2012 | 882 | 0.450 |
Why?
|
Proteins | 4 | 2020 | 6103 | 0.450 |
Why?
|
Myocardial Infarction | 9 | 2023 | 11727 | 0.440 |
Why?
|
Prognosis | 22 | 2021 | 29063 | 0.410 |
Why?
|
Stroke | 12 | 2023 | 9981 | 0.410 |
Why?
|
Fibrinogen | 3 | 2018 | 894 | 0.400 |
Why?
|
Cacao | 2 | 2022 | 98 | 0.390 |
Why?
|
Postmenopause | 2 | 2021 | 2461 | 0.370 |
Why?
|
Risk | 10 | 2019 | 9687 | 0.370 |
Why?
|
Vitamins | 8 | 2023 | 1622 | 0.370 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2021 | 15519 | 0.360 |
Why?
|
Thyroid Gland | 3 | 2024 | 1173 | 0.360 |
Why?
|
Practice Guidelines as Topic | 5 | 2017 | 7279 | 0.350 |
Why?
|
Predictive Value of Tests | 13 | 2019 | 15076 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 12 | 2018 | 9959 | 0.340 |
Why?
|
Pyrroles | 2 | 2014 | 1146 | 0.340 |
Why?
|
Cell Fractionation | 1 | 2009 | 252 | 0.330 |
Why?
|
Hemorrhage | 2 | 2018 | 3461 | 0.330 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 5 | 2018 | 507 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3336 | 0.330 |
Why?
|
Clinical Laboratory Techniques | 2 | 2016 | 738 | 0.320 |
Why?
|
Docosahexaenoic Acids | 4 | 2023 | 875 | 0.320 |
Why?
|
Aortic Valve Stenosis | 4 | 2023 | 1965 | 0.320 |
Why?
|
Sex Characteristics | 2 | 2021 | 2585 | 0.320 |
Why?
|
Preventive Medicine | 1 | 2010 | 264 | 0.310 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 2020 | 1155 | 0.310 |
Why?
|
Hypertension | 7 | 2021 | 8480 | 0.310 |
Why?
|
Atrioventricular Block | 1 | 2009 | 120 | 0.310 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2009 | 151 | 0.300 |
Why?
|
Diet | 3 | 2020 | 7939 | 0.300 |
Why?
|
Hypothyroidism | 3 | 2021 | 658 | 0.290 |
Why?
|
Hypercholesterolemia | 4 | 2018 | 1151 | 0.290 |
Why?
|
Survival Rate | 5 | 2021 | 12788 | 0.290 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2158 | 0.280 |
Why?
|
Chest Pain | 1 | 2013 | 1114 | 0.280 |
Why?
|
Motor Activity | 4 | 2011 | 2714 | 0.280 |
Why?
|
Risk Reduction Behavior | 4 | 2016 | 1125 | 0.280 |
Why?
|
Neoplasms | 12 | 2022 | 21683 | 0.270 |
Why?
|
Guidelines as Topic | 2 | 2010 | 1405 | 0.270 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7913 | 0.270 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 5034 | 0.270 |
Why?
|
Eating | 1 | 2012 | 1536 | 0.270 |
Why?
|
Decision Making | 2 | 2016 | 3887 | 0.260 |
Why?
|
Cause of Death | 4 | 2020 | 3584 | 0.260 |
Why?
|
Eicosapentaenoic Acid | 4 | 2023 | 582 | 0.260 |
Why?
|
Hyperglycemia | 1 | 2014 | 1373 | 0.260 |
Why?
|
Life Style | 3 | 2022 | 3835 | 0.260 |
Why?
|
Age Factors | 7 | 2021 | 18370 | 0.260 |
Why?
|
Diabetic Retinopathy | 1 | 2014 | 1210 | 0.260 |
Why?
|
United States | 18 | 2022 | 69872 | 0.260 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 25043 | 0.260 |
Why?
|
Mortality | 2 | 2016 | 2864 | 0.260 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 604 | 0.250 |
Why?
|
Cohort Studies | 16 | 2023 | 40561 | 0.250 |
Why?
|
Cholesterol, VLDL | 2 | 2017 | 65 | 0.250 |
Why?
|
Thyroxine | 3 | 2024 | 667 | 0.250 |
Why?
|
Sex Factors | 7 | 2020 | 10397 | 0.240 |
Why?
|
Case-Control Studies | 7 | 2024 | 21746 | 0.240 |
Why?
|
Nutrition Surveys | 3 | 2016 | 1660 | 0.240 |
Why?
|
Glomerular Filtration Rate | 3 | 2022 | 2170 | 0.240 |
Why?
|
Consensus | 8 | 2022 | 2959 | 0.240 |
Why?
|
Carotid Arteries | 2 | 2011 | 952 | 0.230 |
Why?
|
Time Factors | 12 | 2020 | 40075 | 0.230 |
Why?
|
Molecular Weight | 2 | 2020 | 2255 | 0.230 |
Why?
|
Program Evaluation | 1 | 2012 | 2488 | 0.230 |
Why?
|
Colorectal Neoplasms | 4 | 2016 | 6773 | 0.220 |
Why?
|
Blood Pressure | 5 | 2018 | 8554 | 0.220 |
Why?
|
Placebos | 2 | 2020 | 1676 | 0.220 |
Why?
|
Leucine | 2 | 2021 | 561 | 0.210 |
Why?
|
Vitamin E | 3 | 2018 | 869 | 0.210 |
Why?
|
Hyperthyroidism | 2 | 2021 | 295 | 0.210 |
Why?
|
Diabetes Mellitus | 4 | 2019 | 5751 | 0.200 |
Why?
|
Communications Media | 1 | 2022 | 43 | 0.200 |
Why?
|
Health Promotion | 2 | 2022 | 2205 | 0.200 |
Why?
|
Adiposity | 3 | 2021 | 1807 | 0.200 |
Why?
|
Disease Progression | 2 | 2019 | 13284 | 0.190 |
Why?
|
Adult | 31 | 2023 | 214055 | 0.190 |
Why?
|
Immunoglobulin G | 3 | 2024 | 4560 | 0.190 |
Why?
|
Models, Theoretical | 1 | 2013 | 3589 | 0.190 |
Why?
|
Breast Neoplasms | 5 | 2022 | 20822 | 0.190 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12261 | 0.180 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2208 | 0.180 |
Why?
|
Reference Values | 3 | 2020 | 4982 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6538 | 0.180 |
Why?
|
Fish Oils | 2 | 2023 | 470 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1790 | 0.180 |
Why?
|
Apolipoprotein E4 | 1 | 2024 | 668 | 0.180 |
Why?
|
Mendelian Randomization Analysis | 3 | 2021 | 967 | 0.180 |
Why?
|
Secondary Prevention | 3 | 2019 | 1530 | 0.180 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2278 | 0.170 |
Why?
|
Angina, Unstable | 3 | 2013 | 926 | 0.170 |
Why?
|
Chemistry, Clinical | 2 | 2016 | 64 | 0.170 |
Why?
|
Societies, Medical | 4 | 2020 | 3743 | 0.170 |
Why?
|
Peripheral Arterial Disease | 3 | 2019 | 1188 | 0.170 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2021 | 315 | 0.170 |
Why?
|
Oxylipins | 1 | 2019 | 49 | 0.170 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2022 | 262 | 0.170 |
Why?
|
Morbidity | 2 | 2017 | 1769 | 0.160 |
Why?
|
Hemostasis | 1 | 2021 | 458 | 0.160 |
Why?
|
Diet, Reducing | 1 | 2022 | 462 | 0.160 |
Why?
|
Apolipoprotein C-III | 1 | 2019 | 202 | 0.160 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.160 |
Why?
|
Cardiology | 3 | 2019 | 1668 | 0.160 |
Why?
|
North America | 1 | 2021 | 1249 | 0.160 |
Why?
|
Fatty Acids | 3 | 2023 | 1809 | 0.160 |
Why?
|
Databases, Protein | 1 | 2020 | 383 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12245 | 0.160 |
Why?
|
Asthma | 1 | 2017 | 6011 | 0.160 |
Why?
|
Overweight | 3 | 2023 | 2371 | 0.150 |
Why?
|
Confidence Intervals | 2 | 2014 | 2971 | 0.150 |
Why?
|
Specimen Handling | 1 | 2022 | 694 | 0.150 |
Why?
|
Thyroid Hormones | 1 | 2020 | 390 | 0.150 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.150 |
Why?
|
Heart Valves | 1 | 2019 | 291 | 0.150 |
Why?
|
Up-Regulation | 4 | 2019 | 4217 | 0.150 |
Why?
|
Immunoassay | 2 | 2014 | 752 | 0.150 |
Why?
|
Age of Onset | 2 | 2021 | 3271 | 0.150 |
Why?
|
Eicosanoids | 1 | 2019 | 279 | 0.150 |
Why?
|
Treatment Outcome | 12 | 2022 | 63114 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2010 | 3923 | 0.140 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2017 | 187 | 0.140 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15540 | 0.130 |
Why?
|
Thyroid Diseases | 1 | 2019 | 379 | 0.130 |
Why?
|
Caloric Restriction | 1 | 2018 | 302 | 0.130 |
Why?
|
Prevalence | 6 | 2020 | 15226 | 0.130 |
Why?
|
Preventive Health Services | 1 | 2000 | 575 | 0.130 |
Why?
|
Europe | 3 | 2016 | 3339 | 0.130 |
Why?
|
Vitamin D Deficiency | 2 | 2022 | 1343 | 0.130 |
Why?
|
Lipid Metabolism | 2 | 2021 | 1889 | 0.130 |
Why?
|
Peptic Ulcer | 1 | 2016 | 223 | 0.130 |
Why?
|
Smoking | 4 | 2021 | 8987 | 0.130 |
Why?
|
Diabetic Nephropathies | 1 | 2022 | 984 | 0.120 |
Why?
|
Ion Transport | 1 | 2015 | 320 | 0.120 |
Why?
|
Algorithms | 4 | 2021 | 13881 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 8 | 2021 | 17446 | 0.120 |
Why?
|
Chemoprevention | 1 | 2016 | 319 | 0.120 |
Why?
|
Myocardial Revascularization | 2 | 2020 | 841 | 0.120 |
Why?
|
ROC Curve | 2 | 2015 | 3527 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13989 | 0.120 |
Why?
|
Thyrotropin | 3 | 2024 | 849 | 0.120 |
Why?
|
Blood Vessels | 1 | 2019 | 1125 | 0.120 |
Why?
|
Physical Endurance | 2 | 2006 | 370 | 0.110 |
Why?
|
Cardiovascular System | 1 | 2021 | 832 | 0.110 |
Why?
|
Aged, 80 and over | 14 | 2021 | 57776 | 0.110 |
Why?
|
Hematuria | 1 | 2014 | 235 | 0.110 |
Why?
|
Homocysteine | 2 | 2007 | 647 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2018 | 969 | 0.110 |
Why?
|
Ligands | 1 | 2020 | 3282 | 0.110 |
Why?
|
Benchmarking | 2 | 2009 | 1042 | 0.110 |
Why?
|
Fibroblast Growth Factors | 1 | 2018 | 879 | 0.110 |
Why?
|
Genotype | 7 | 2024 | 12951 | 0.110 |
Why?
|
Aorta, Thoracic | 1 | 2019 | 1082 | 0.110 |
Why?
|
Ultrasonography | 3 | 2012 | 5985 | 0.110 |
Why?
|
Calcium | 2 | 2023 | 5756 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2401 | 0.100 |
Why?
|
Carotid Artery, Common | 1 | 2012 | 183 | 0.100 |
Why?
|
Blood Proteins | 1 | 2016 | 1124 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2022 | 19905 | 0.090 |
Why?
|
Lipoproteins, IDL | 1 | 2010 | 18 | 0.090 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 551 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2013 | 601 | 0.090 |
Why?
|
Research | 1 | 2019 | 1999 | 0.090 |
Why?
|
Early Termination of Clinical Trials | 1 | 2010 | 68 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3616 | 0.090 |
Why?
|
Creatinine | 3 | 2020 | 1919 | 0.090 |
Why?
|
Triiodothyronine | 2 | 2024 | 494 | 0.090 |
Why?
|
Down-Regulation | 1 | 2017 | 3002 | 0.090 |
Why?
|
Carotid Artery, Internal | 1 | 2012 | 445 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2013 | 1590 | 0.090 |
Why?
|
Metabolomics | 1 | 2018 | 1484 | 0.090 |
Why?
|
Middle East | 2 | 2020 | 219 | 0.090 |
Why?
|
Treatment Failure | 3 | 2021 | 2618 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2021 | 1620 | 0.090 |
Why?
|
Odds Ratio | 3 | 2014 | 9849 | 0.080 |
Why?
|
Heart | 1 | 2022 | 4467 | 0.080 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.080 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2016 | 1130 | 0.080 |
Why?
|
Thyroid Function Tests | 2 | 2020 | 286 | 0.080 |
Why?
|
Kidney Diseases | 1 | 2020 | 2149 | 0.080 |
Why?
|
Psoriasis | 1 | 2016 | 898 | 0.080 |
Why?
|
Diabetes, Gestational | 1 | 2018 | 1184 | 0.080 |
Why?
|
Comorbidity | 4 | 2020 | 10388 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2902 | 0.080 |
Why?
|
Heart Failure | 3 | 2022 | 10900 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10943 | 0.080 |
Why?
|
Angioplasty | 1 | 2010 | 364 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.070 |
Why?
|
American Heart Association | 1 | 2012 | 1056 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.070 |
Why?
|
Hospitalization | 3 | 2022 | 10262 | 0.070 |
Why?
|
Genome, Human | 2 | 2017 | 4420 | 0.070 |
Why?
|
Physician-Patient Relations | 1 | 2000 | 3229 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 4933 | 0.070 |
Why?
|
Hospital Mortality | 1 | 2020 | 5317 | 0.070 |
Why?
|
Communication | 1 | 2000 | 3749 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2013 | 1547 | 0.070 |
Why?
|
Calibration | 1 | 2009 | 816 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2636 | 0.070 |
Why?
|
Liver Diseases | 1 | 2014 | 1253 | 0.070 |
Why?
|
Software | 1 | 2020 | 4443 | 0.070 |
Why?
|
Parathyroid Hormone | 2 | 2023 | 1801 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 284 | 0.070 |
Why?
|
Muscular Diseases | 1 | 2010 | 556 | 0.070 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4644 | 0.070 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2014 | 1004 | 0.070 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.060 |
Why?
|
Waist Circumference | 2 | 2020 | 917 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.060 |
Why?
|
Vitamin B Complex | 1 | 2007 | 288 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4558 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3610 | 0.060 |
Why?
|
Kidney | 1 | 2020 | 7186 | 0.060 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2012 | 980 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6895 | 0.060 |
Why?
|
Canada | 2 | 2022 | 2065 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3309 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1541 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2886 | 0.060 |
Why?
|
Air Pollutants | 1 | 2017 | 2817 | 0.060 |
Why?
|
Child | 3 | 2021 | 77709 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9146 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2005 | 340 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5256 | 0.050 |
Why?
|
Data Collection | 1 | 2012 | 3341 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2006 | 370 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2017 | 4234 | 0.050 |
Why?
|
Thrombosis | 2 | 2006 | 2968 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4215 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14722 | 0.050 |
Why?
|
Heart Arrest | 1 | 2012 | 1470 | 0.050 |
Why?
|
Isoleucine | 1 | 2021 | 112 | 0.050 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.050 |
Why?
|
Adolescent | 4 | 2022 | 85781 | 0.050 |
Why?
|
Trace Elements | 1 | 2023 | 198 | 0.050 |
Why?
|
Boston | 1 | 2014 | 9313 | 0.050 |
Why?
|
Diabetes Complications | 1 | 2008 | 1359 | 0.050 |
Why?
|
Epidemiologic Methods | 2 | 2021 | 1364 | 0.050 |
Why?
|
Prediabetic State | 1 | 2006 | 499 | 0.050 |
Why?
|
Siblings | 1 | 2005 | 854 | 0.050 |
Why?
|
Intention to Treat Analysis | 1 | 2022 | 426 | 0.050 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 263 | 0.050 |
Why?
|
Fibrinolysis | 1 | 2021 | 322 | 0.050 |
Why?
|
Cation Transport Proteins | 1 | 2023 | 327 | 0.050 |
Why?
|
Folic Acid | 1 | 2007 | 1300 | 0.050 |
Why?
|
Genetic Loci | 1 | 2009 | 2575 | 0.050 |
Why?
|
Family Health | 1 | 2005 | 1282 | 0.040 |
Why?
|
Internet | 1 | 2012 | 3064 | 0.040 |
Why?
|
Africa, Northern | 1 | 2019 | 82 | 0.040 |
Why?
|
Nomograms | 1 | 2021 | 228 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 604 | 0.040 |
Why?
|
Blood Coagulation Factors | 1 | 2021 | 355 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2011 | 4456 | 0.040 |
Why?
|
Plant Extracts | 1 | 2022 | 471 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 676 | 0.040 |
Why?
|
Blood Glucose | 2 | 2018 | 6256 | 0.040 |
Why?
|
Femur Neck | 1 | 2020 | 309 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2024 | 1438 | 0.040 |
Why?
|
Young Adult | 4 | 2022 | 56430 | 0.040 |
Why?
|
DNA | 2 | 2010 | 7301 | 0.040 |
Why?
|
Autocrine Communication | 1 | 1999 | 171 | 0.040 |
Why?
|
Myometrium | 1 | 1999 | 181 | 0.040 |
Why?
|
Phenotype | 3 | 2021 | 16365 | 0.040 |
Why?
|
Muscles | 1 | 2023 | 1614 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 684 | 0.040 |
Why?
|
Linear Models | 2 | 2019 | 5952 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 513 | 0.040 |
Why?
|
Bone Density | 2 | 2021 | 3468 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2021 | 669 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 357 | 0.040 |
Why?
|
Paracrine Communication | 1 | 1999 | 277 | 0.040 |
Why?
|
Regression Analysis | 1 | 2007 | 6459 | 0.040 |
Why?
|
Iodide Peroxidase | 1 | 2019 | 293 | 0.040 |
Why?
|
Premenopause | 1 | 2021 | 1033 | 0.040 |
Why?
|
Prolactin | 1 | 1999 | 669 | 0.040 |
Why?
|
Attitude | 1 | 2022 | 776 | 0.040 |
Why?
|
Growth Substances | 1 | 1999 | 784 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2021 | 1344 | 0.030 |
Why?
|
England | 1 | 2017 | 522 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7785 | 0.030 |
Why?
|
Glycomics | 1 | 2017 | 121 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5391 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2170 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2019 | 1572 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2019 | 764 | 0.030 |
Why?
|
Water | 1 | 2021 | 1395 | 0.030 |
Why?
|
Body Weight | 1 | 2005 | 4669 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12959 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2020 | 1725 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1493 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2000 | 2539 | 0.030 |
Why?
|
Animals | 3 | 2020 | 168757 | 0.030 |
Why?
|
Leiomyoma | 1 | 1999 | 730 | 0.030 |
Why?
|
Pulse | 1 | 2013 | 229 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2035 | 0.030 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 16718 | 0.030 |
Why?
|
Erythrocytes | 1 | 2022 | 2455 | 0.030 |
Why?
|
Survival Analysis | 1 | 2005 | 10252 | 0.030 |
Why?
|
Electrocardiography | 1 | 2005 | 6442 | 0.030 |
Why?
|
Nurses | 1 | 2021 | 2461 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 6993 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6489 | 0.020 |
Why?
|
Quality of Life | 1 | 2012 | 12804 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1990 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2622 | 0.020 |
Why?
|
Viral Load | 1 | 2019 | 3299 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3200 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.020 |
Why?
|
Uterine Neoplasms | 1 | 1999 | 1513 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2118 | 0.020 |
Why?
|
Genetic Markers | 1 | 2015 | 2634 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3521 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2013 | 554 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1519 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2016 | 77449 | 0.020 |
Why?
|
Aging | 1 | 2006 | 8664 | 0.020 |
Why?
|
Insulin | 1 | 2022 | 6580 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2015 | 2309 | 0.020 |
Why?
|
Smoking Cessation | 1 | 2018 | 2071 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6770 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3913 | 0.020 |
Why?
|
Models, Statistical | 1 | 2021 | 5102 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3114 | 0.020 |
Why?
|
Logistic Models | 1 | 2000 | 13408 | 0.020 |
Why?
|
Patient Participation | 1 | 2014 | 1457 | 0.020 |
Why?
|
Quality of Health Care | 2 | 2009 | 4371 | 0.010 |
Why?
|
Medicare | 1 | 2022 | 6566 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3588 | 0.010 |
Why?
|
Depression | 1 | 2023 | 7766 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 5987 | 0.010 |
Why?
|
Hemodynamics | 1 | 2013 | 4199 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2011 | 3279 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6933 | 0.010 |
Why?
|
Receptors, Prolactin | 1 | 1999 | 17 | 0.010 |
Why?
|
Models, Genetic | 1 | 2009 | 3494 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1999 | 803 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 6171 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2007 | 2716 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4328 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1999 | 1799 | 0.010 |
Why?
|
Cell Count | 1 | 1999 | 1856 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13695 | 0.010 |
Why?
|
Mitosis | 1 | 1999 | 1208 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13102 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4751 | 0.010 |
Why?
|
Cell Division | 1 | 1999 | 4568 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1999 | 6314 | 0.010 |
Why?
|
Antibodies | 1 | 1999 | 2460 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1999 | 13033 | 0.000 |
Why?
|